Allen E Meske, MD in Martinsboro, WV - Emergency Medicine

Allen E Meske, MD is a Emergency Medicine physician based in Martinsboro, West Virginia. Allen E Meske is licensed to practice in West Virginia (license number 22565) and his current practice location is 2500 Hospital Drive, Martinsboro, West Virginia. He can be reached at his office (for appointments etc.) via phone at (304) 264-1000.

NPI number for Allen E Meske is 1821012956 and his current mailing address is Po Box 1150, Martinsboro, West Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1821012956.

Contact Information

	Allen E Meske, MD
	2500 Hospital Drive, Martinsboro, WV 25401
	(304) 264-1000
	(304) 264-1374

Physician's Profile

Full Name	Allen E Meske
Gender	Male
Speciality	Emergency Medicine
Location	2500 Hospital Drive, Martinsboro, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1821012956
Provider Enumeration Date: 07/26/2006
Last Update Date: 05/24/2010

Medical Identifiers

Medical identifiers for Allen E Meske such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821012956	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	71415 (Florida)	Secondary
207P00000X	Emergency Medicine	22565 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Allen E Meske is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Allen E Meske, MD Po Box 1150, Martinsboro, WV 25402-1150 Ph: (304) 264-1000	Allen E Meske, MD 2500 Hospital Drive, Martinsboro, WV 25401 Ph: (304) 264-1000

News Archive

Study provides epidemiology of fatal occupational traumatic brain injury in the U.S.

Although traumatic brain injury (TBI) is one of the leading causes of death in the United States, work-related TBI has not been well documented. In a study published in the July issue of the American Journal of Preventive Medicine, researchers describe the epidemiology of fatal TBI in the US workplace between 2003 and 2008.

Monoclonal antibodies induce long-lasting, protective antiviral immune response

Monoclonal antibodies are the largest class of biotherapeutic drugs. When administered to infected organisms to blunt the propagation of pathogenic viruses, they may also induce a long-lasting and protective antiviral immune response similar to that achieved by vaccination. These results obtained in mice by the "Oncogenèse et Immunothérapie" group at the Institut de Génétique Moléculaire de Montpellier (CNRS/Universités Montpellier 1 and 2), have been published on 10 June in PLoS Pathogens.

Combination therapy including antibiotics may be beneficial for multiple sclerosis

A preliminary study suggests that combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease, according to an article posted online today that will appear in the February 2008 print issue of Archives of Neurology.

HHS announces $250 million in federal funding to boost primary care providers

The Washington Post: "In an attempt to address a national shortage of health-care workers, Health and Human Services Secretary Kathleen Sebelius said Wednesday that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers. The money ... includes $168 million to train 500 new primary-care physicians over the next five years, $30 million to encourage 600 nursing students to attend school full-time and complete their education, and $32 million to create 600 new physician assistants."

Meclizine drug has the potential to treat certain infectious diseases and cancer

Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases and some forms of cancer, according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist.

Allen E Meske, MD - Emergency Medicine in Martinsboro, WV